Pediatric Psychopharmacology Evidence Un Guide du clinicien

  • en
  • Couverture rigide
  • 9783031574719
  • 13 octobre 2024
  • 560 pages
Toutes les spécifications de l'article

Résumé

This book is a comprehensive guide to pediatric psychopharmacology, detailing medications used to treat a wide variety of childhood and adolescent mental illnesses.



This book is a comprehensive guide to pediatric psychopharmacology, detailing medications used to treat a wide variety of childhood and adolescent mental illnesses. Childhood and adolescence represent critically important life stages in cognitive, social, and emotional development. Unfortunately, the prevalence of mental illness has been growing over the last several decades, especially among children. It is estimated that suicide is the second most common cause of death among adolescents and young adults in the United States. A crucial component of evidence-based mental health treatment of youth consists of careful, sophisticated, and compassionate medication treatment.

This guide is divided into 18 chapters, with most covering the medications used to treat a specific disorder or group of disorders. Chapters comprehensively cover each medication’s history, FDA indication status and context, representation in the media, mechanism, extent of usage and research, and quality of evidence supporting its efficacy and safety. Chapters also cover approaches clinicians can use to discuss medications with patients—including alternative treatment options and integrating patient-level variables when choosing a medication. This book focuses on understanding patient and family perspectives on medication with suggested clinician responses to better communicate about prescription management. Chapters also include tables and figures, list resources and guidelines, and discuss controversies in the media.

All prescribers to children and adolescents will find Pediatric Psychopharmacology Evidence to be a timely, comprehensive, and compassionate guide to the pharmacological treatment of young patients with mental illness.



This book is a comprehensive guide to pediatric psychopharmacology, detailing medications used to treat a wide variety of childhood and adolescent mental illnesses. Childhood and adolescence represent critically important life stages in cognitive, social, and emotional development. Unfortunately, the prevalence of mental illness has been growing over the last several decades, especially among children. It is estimated that suicide is the second most common cause of death among adolescents and young adults in the United States. A crucial component of evidence-based mental health treatment of youth consists of careful, sophisticated, and compassionate medication treatment.

This guide is divided into 18 chapters, with most covering the medications used to treat a specific disorder or group of disorders. Chapters comprehensively cover each medication’s history, FDA indication status and context, representation in the media, mechanism, extent of usage and research, and quality of evidence supporting its efficacy and safety. Chapters also cover approaches clinicians can use to discuss medications with patients—including alternative treatment options and integrating patient-level variables when choosing a medication. This book focuses on understanding patient and family perspectives on medication with suggested clinician responses to better communicate about prescription management. Chapters also include tables and figures, list resources and guidelines, and discuss controversies in the media.

All prescribers to children and adolescents will find Pediatric Psychopharmacology Evidence to be a timely, comprehensive, and compassionate guide to the pharmacological treatment of young patients with mental illness.

Spécifications produit

Contenu

Langue
en
Version
Couverture rigide
Date de sortie initiale
13 octobre 2024
Nombre de pages
560

Personnes impliquées

Auteur principal
Boris Lorberg
Rédacteur en chef
Boris Lorberg

Autres spécifications

Hauteur de l'emballage
39 mm
Largeur d'emballage
187 mm
Largeur du produit
178 mm
Longueur d'emballage
262 mm
Longueur du produit
254 mm
Poids de l'emballage
1478 g

EAN

EAN
9783031574719

Sécurité des produits

Opérateur économique responsable dans l’UE
Afficher les données
Pas encore d'avis
Choisissez la version souhaitée
Version : Couverture rigide
Informations sur les prix et commande
Le prix de ce produit est de 199 euros.
Attendu dans environ 3 semaines
Vendu par bol
  • Livraison comprise avec bol
  • Retrait possible dans un point-relais bol
  • 30 jours de réflexion et retour gratuit
  • Garantie légale via bol
  • Service client 24h/24